Kumiko Ohta

527 total citations
21 papers, 413 citations indexed

About

Kumiko Ohta is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Kumiko Ohta has authored 21 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Hematology and 3 papers in Oncology. Recurrent topics in Kumiko Ohta's work include Epigenetics and DNA Methylation (3 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). Kumiko Ohta is often cited by papers focused on Epigenetics and DNA Methylation (3 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). Kumiko Ohta collaborates with scholars based in Japan, United States and Poland. Kumiko Ohta's co-authors include T. Takabatake, Atsushi Hirao, Ise T, Yuko Tadokoro, Masahiko Kobayashi, Takayuki Hoshii, Masaya Ueno, Ikuyoshi Tomita, Mohamed Ashraf Ali and Daisuke Yamada and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and American Journal of Clinical Nutrition.

In The Last Decade

Kumiko Ohta

21 papers receiving 395 citations

Peers

Kumiko Ohta
Torsten Hoff Germany
Jung Eun Kim South Korea
Ji Eun Lee South Korea
L Turecký Slovakia
Munish Kumar United States
Kumiko Ohta
Citations per year, relative to Kumiko Ohta Kumiko Ohta (= 1×) peers Jer-Chia Tsai

Countries citing papers authored by Kumiko Ohta

Since Specialization
Citations

This map shows the geographic impact of Kumiko Ohta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kumiko Ohta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kumiko Ohta more than expected).

Fields of papers citing papers by Kumiko Ohta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kumiko Ohta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kumiko Ohta. The network helps show where Kumiko Ohta may publish in the future.

Co-authorship network of co-authors of Kumiko Ohta

This figure shows the co-authorship network connecting the top 25 collaborators of Kumiko Ohta. A scholar is included among the top collaborators of Kumiko Ohta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kumiko Ohta. Kumiko Ohta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tadokoro, Yuko, Takayuki Hoshii, Satoshi Yamazaki, et al.. (2018). Spred1 Safeguards Hematopoietic Homeostasis against Diet-Induced Systemic Stress. Cell stem cell. 22(5). 713–725.e8. 27 indexed citations
2.
Yamada, Daisuke, Masahiko Kobayashi, Susumu Kohno, et al.. (2016). Therapeutic Strategy for Targeting Aggressive Malignant Gliomas by Disrupting Their Energy Balance. Journal of Biological Chemistry. 291(41). 21496–21509. 31 indexed citations
3.
Kawahara, Teppei, Noritaka Kagaya, Yuichi Masuda, et al.. (2015). Foxo3a Inhibitors of Microbial Origin, JBIR-141 and JBIR-142. Organic Letters. 17(21). 5476–5479. 9 indexed citations
4.
Ali, Mohamed Ashraf, Kazuhito Naka, Takayuki Hoshii, et al.. (2014). Association of a murine leukaemia stem cell gene signature based on nucleostemin promoter activity with prognosis of acute myeloid leukaemia in patients. Biochemical and Biophysical Research Communications. 450(1). 837–843. 4 indexed citations
5.
Tanaka, Shingo, Mitsutoshi Nakada, Daisuke Yamada, et al.. (2014). Strong therapeutic potential of γ-secretase inhibitor MRK003 for CD44-high and CD133-low glioblastoma initiating cells. Journal of Neuro-Oncology. 121(2). 239–250. 19 indexed citations
6.
Ooshio, Takako, Kenichi Harada, Kazuhito Naka, et al.. (2013). Abundant Nucleostemin Expression Supports the Undifferentiated Properties of Germ Cell Tumors. American Journal Of Pathology. 183(2). 592–603. 8 indexed citations
7.
Yamada, Daisuke, Takayuki Hoshii, Shingo Tanaka, et al.. (2013). Loss of Tsc1 accelerates malignant gliomagenesis when combined with oncogenic signals. The Journal of Biochemistry. 155(4). 227–233. 17 indexed citations
8.
Niida, Hiroyuki, Kazuhiro Murata, Midori Shimada, et al.. (2010). Cooperative functions of Chk1 and Chk2 reduce tumour susceptibility in vivo. The EMBO Journal. 29(20). 3558–3570. 47 indexed citations
9.
Ohta, Kumiko, Hiromi Ikeda, Masaharu Sakai, et al.. (2007). Histone acetyltransferase MOZ acts as a co-activator of Nrf2–MafK and induces tumour marker gene expression during hepatocarcinogenesis. Biochemical Journal. 402(3). 559–566. 40 indexed citations
10.
Yang, Yonghong, Kumiko Ohta, Masaru Shimizu, et al.. (2005). Treatment with low-dose angiotensin-converting enzyme inhibitor (ACEI) plus angiotensin II receptor blocker (ARB) in pediatric patients with IgA nephropathy. Clinical Nephrology. 64(7). 35–40. 30 indexed citations
11.
Shimizu, Makiko, Kumiko Ohta, Reiko Matsushita, et al.. (2003). Effects of Aspirin and/or Salicylate on Hydrolysis and Glucuronidation of Indomethacin in Rat Erythrocytes and Hepatocytes. Biological and Pharmaceutical Bulletin. 26(5). 675–682. 1 indexed citations
12.
Hino, Masao, Naoki Oiso, Shinichi Nishi, et al.. (2001). Virus-associated hemophagocytic syndrome due to rubella virus and varicella-zoster virus dual infection in patient with adult idiopathic thrombocytopenic purpura. Annals of Hematology. 80(6). 361–364. 13 indexed citations
13.
Ozawa, Shuichi, Kumiko Ohta, Atsuko Miyajima, et al.. (2000). Metabolic activation ofo-phenylphenol to a major cytotoxic metabolite, phenylhydroquinone: role of human CYP1A2 and rat CYP2C11/CYP2E1. Xenobiotica. 30(10). 1005–1017. 17 indexed citations
14.
Ohta, Kumiko, et al.. (2000). [B precursor lymphoblastic leukemia/lymphoma manifested at onset as hemophagocytic syndrome].. PubMed. 48(10). 975–9. 5 indexed citations
15.
Takabatake, T., Hiroyuki Ohta, Shinya Nakamura, et al.. (1994). Effects of an angiotensin II receptor antagonist, TCV-116, on renal haemodynamics in essential hypertension.. PubMed. 5. 117–21. 25 indexed citations
16.
Takabatake, T., et al.. (1993). Renal effects of manidipine hydrochloride. European Journal of Clinical Pharmacology. 45(4). 321–5. 19 indexed citations
17.
Takabatake, T., Ise T, Kumiko Ohta, & K. Kobayashi. (1992). Effects of endothelin on renal hemodynamics and tubuloglomerular feedback. American Journal of Physiology-Renal Physiology. 263(1). F103–F108. 20 indexed citations
18.
Takabatake, T., Yoshiyuki Yamamoto, Yasuyuki Ushiogi, et al.. (1991). Pharmacokinetics of SUN 1165, a new antiarrhythmic agent, in renal dysfunction. European Journal of Clinical Pharmacology. 40(4). 411–414. 16 indexed citations
19.
Niwa, Toshiro, et al.. (1980). Tryptophan and indolic tryptophan metabolites in chronic renal failure. American Journal of Clinical Nutrition. 33(7). 1402–1406. 30 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026